Zobrazeno 1 - 10
of 302
pro vyhledávání: '"Robin K Avery"'
Publikováno v:
Transplant International, Vol 36 (2023)
Despite advances in monitoring and treatment, cytomegalovirus (CMV) infections remain one of the most common complications after solid organ transplantation (SOT). CMV infection may fail to respond to standard first- and second-line antiviral therapi
Externí odkaz:
https://doaj.org/article/902cd30c4bab43dba3d4c1f646f5f523
Autor:
Amy Chang, Alexandra T. Strauss, Jennifer L. Alejo, Teresa P.‐Y. Chiang, Nicole F. Hernandez, Laura B. Zeiser, Brian J. Boyarsky, Robin K. Avery, Aaron A. R. Tobian, Macey L. Levan, Daniel S. Warren, Jacqueline M. Garonzik‐Wang, Allan B. Massie, William A. Werbel, Dorry L. Segev
Publikováno v:
Hepatology Communications, Vol 6, Iss 10, Pp 2990-2992 (2022)
Externí odkaz:
https://doaj.org/article/0eecdc7b23ce4b508924797d632228ef
Autor:
Guy Shapira, Hadas Volkov, Itai Fabian, David W. Mohr, Maria Bettinotti, Noam Shomron, Robin K. Avery, Ravit Arav-Boger
Publikováno v:
Viruses, Vol 15, Iss 11, p 2227 (2023)
Human cytomegalovirus (CMV) is a major pathogen after solid organ transplantation, leading to high morbidity and mortality. Transplantation from a CMV-seropositive donor to a CMV-seronegative recipient (D+/R−) is associated with high risk of CMV di
Externí odkaz:
https://doaj.org/article/5b4c2c20f1ef416ab5d7833d0dd586b6
Autor:
Bo-Yi Sung, Yi-Hsin Lin, Qiongman Kong, Pali D. Shah, Joan Glick Bieler, Scott Palmer, Kent J. Weinhold, Hong-Ru Chang, Hailiang Huang, Robin K. Avery, Jonathan Schneck, Yen-Ling Chiu
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 2 (2022)
T cell polyfunctionality is a hallmark of protective immunity against pathogens and cancer, yet the molecular mechanism governing it remains mostly elusive. We found that canonical Wnt agonists inhibited human memory CD8+ T cell differentiation while
Externí odkaz:
https://doaj.org/article/77323b0e1f494b908dd717617dd58e01
Autor:
Afrah S. Sait, MD, Teresa Po-Yu Chiang, MD, MPH, Kieren A. Marr, MD, MBA, Allan B. Massie, PhD, Willa Cochran, CRNP, Pali Shah, MD, Daniel C. Brennan, MD, Alvin G. Thomas, MS, Seema Mehta Steinke, MD, MS, Nitipong Permpalung, MD, MPH, Shmuel Shoham, MD, Christian Merlo, MD, Tania Jain, MD, Brian Boyarsky, MD, Olga Charnaya, MD, Ahmet Gurakar, MD, Kavita Sharma, MD, Christine M. Durand, MD, William A. Werbel, MD, Chiung-Yu Huang, PhD, Darin Ostrander, PhD, Niraj Desai, MD, Min Young Kim, MD, Sami Alasfar, MD, Evan M. Bloch, MD, PhD, Aaron A.R. Tobian, MD PhD, Jacqueline Garonzik-Wang, MD, PhD, Dorry L. Segev, MD, PhD, Robin K. Avery, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 1, p e1268 (2022)
Background. Few reports have focused on newer coronavirus disease 2019 (COVID-19) therapies (remdesivir, dexamethasone, and convalescent plasma) in solid organ transplant recipients; concerns had been raised regarding possible adverse impact on allog
Externí odkaz:
https://doaj.org/article/d43f8a7fd91142afa711d1b861dece4a
Autor:
Michelle C. Nguyen, MD, MPH, Eliza J. Lee, MD, Robin K. Avery, MD, M. Veronica Dioverti-Prono, MD, Shmuel Shoham, MD, Aaron A. R. Tobian, MD, PhD, Evan M. Bloch, MBChB, Ahmet Gurakar, MD, Nicole A. Rizkalla, MD, Andrew M. Cameron, MD, PhD, Elizabeth A. King, MD, PhD, Shane Ottmann, MD, Jacqueline M. Garonzik-Wang, MD, PhD, Russel N. Wesson, MBChB, Benjamin Philosophe, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 8, p e721 (2021)
Given the high community prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), transplant programs will encounter SARS-CoV-2 infections in living donors or recipients in the perioperative period. There is limited data on SARS-Co
Externí odkaz:
https://doaj.org/article/17bd110d1d034f22a6e67e345093c144
Autor:
Michael T. Ou, BS, Brian J. Boyarsky, MD, Laura B. Zeiser, ScM, Teresa Po-Yu Chiang, MD, MPH, Jake Ruddy, BS, Sarah E. Van Pilsum Rasmussen, BA, Jennifer Martin, Jennifer St. Clair Russell, PhD, MSEd, MCHES, Christine M. Durand, MD, Robin K. Avery, MD, William A. Werbel, MD, Matthew Cooper, MD, Allan B. Massie, PhD, MHS, Dorry L. Segev, MD, PhD, Jacqueline M. Garonzik-Wang, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 7, p e713 (2021)
Background. A widely accepted severe acute respiratory syndrome 2 (SARS-CoV-2) vaccine could protect vulnerable populations, but the willingness of solid organ transplant recipients (SOTRs) to accept a potential vaccine remains unknown. Methods. We c
Externí odkaz:
https://doaj.org/article/849ce0396d6d4005a3cfadbc8e1aa618
Autor:
Andrew H. Karaba, Jake D. Kim, Teresa P-Y. Chiang, Jennifer L. Alejo, Ioannis Sitaras, Aura T. Abedon, Yolanda Eby, Trevor Scott Johnston, Maggie Li, Tihitina Aytenfisu, Casey Hussey, Alexa Jefferis, Nicole Fortune, Rivka Abedon, Letitia Thomas, Feben Habtehyimer, Jessica Ruff, Daniel S. Warren, Robin K. Avery, William A. Clarke, Andrew Pekosz, Allan B. Massie, Aaron A.R. Tobian, Dorry L. Segev, William A. Werbel
Publikováno v:
American Journal of Transplantation. 23:423-428
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4152143328d84cf8b2e31daeb244a13
https://doi.org/10.1016/j.ajt.2022.11.002
https://doi.org/10.1016/j.ajt.2022.11.002
Autor:
Brian J. Boyarsky, MD, Allan B. Massie, PhD, Arthur D. Love, BS, William A. Werbel, MD, Christine M. Durand, MD, Robin K. Avery, MD, Kyle R. Jackson, MD, PhD, Amber B. Kernodle, MD, MPH, Alvin G. Thomas, MSPH, Matthew Ronin, BA, Michelle Altrich, PhD, Patricia Niles, BS, RN, Chad Trahan, BSN, Jonathan Hewlett, BA, Dorry L. Segev, MD, PhD, Jacqueline M. Garonzik-Wang, MD, PhD
Publikováno v:
Transplantation Direct, Vol 6, Iss 7, p e572 (2020)
Background. The early effects of coronavirus disease 2019 (COVID-19) on transplantation are dramatic: >75% of kidney and liver programs are either suspended or operating under major restrictions. To resume transplantation, it is important to understa
Externí odkaz:
https://doaj.org/article/72dd57ec71d741278be7a13572b666d8
Autor:
Teresa PY Chiang, Jennifer L. Alejo, Jonathan Mitchell, Jake D. Kim, Aura T. Abedon, Andrew H. Karaba, Letitia Thomas, Macey L. Levan, Jacqueline M. Garonzik-Wang, Robin K. Avery, Andrew Pekosz, William A. Clarke, Daniel S. Warren, Aaron A.R. Tobian, Allan B. Massie, Dorry L. Segev, William A. Werbel
Publikováno v:
American Journal of Transplantation. 22:2254-2260
Heterologous vaccination ("mixing platforms") for the third (D3) dose of SARS-CoV-2 vaccine is a potential strategy to improve antibody responses in solid organ transplant recipients (SOTRs), but data are mixed regarding potential differential immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7448c002e934c7ace26c013d41a9e6
https://doi.org/10.1111/ajt.17061
https://doi.org/10.1111/ajt.17061